Pipeline Therapeutics
Jason Stricker has a diverse work experience in the field of scientific research. Jason began as a Research Associate at Exelixis in 2001 and then moved on to work as a Research Scientist II at Novartis from 2005 to 2012. Following their time at Novartis, Jason joined Acorda Therapeutics, Inc. as an Associate Scientist from 2012 to 2017. In 2016, they briefly served as a Mentor for the MS Society. Most recently, Jason worked at Zafrens as a Senior Scientist-Biology-Technology Integration from 2022 to 2023. Jason is currently working as a Senior Scientist at Pipeline Therapeutics.
Jason Stricker has a Master's degree in Molecular Biology from SUNY Brockport. The specific start and end years of their education are not provided.
Pipeline Therapeutics
Pipeline Therapeutics is a biopharmaceutical company focused on the development and commercialization of first-in-class small molecules for neuroregeneration, including synaptogenesis, remyelination, and axonal repair.